Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anxiety
- Depression
- Fatigue
- Pain
- Sleep Disturbance
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: We will conduct a cluster randomized pragmatic trial with a stepped wedge design to test the hypothesis that the E2C2 intervention will significantly reduce SPADE symptom scores, reduce unplanned hospitalizations and emergency department visits, increase adherence to cancer therapies, improve physical function, and enhance quality of life (QoL).Masking: None (Open Label)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial tests whether systematically assessing patient reported outcomes for sleep disturbance, pain, anxiety, depression, and fatigue among patients with solid and liquid malignancies and using these data to increase the f...
The Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial tests whether systematically assessing patient reported outcomes for sleep disturbance, pain, anxiety, depression, and fatigue among patients with solid and liquid malignancies and using these data to increase the frequency of guideline-concordant care by: 1) reporting these data to their clinical teams, 2) providing patients with needs-matched symptom self-management education, and 3) suggesting evidence-based symptom management strategies to their care teams improves patients' quality of life, symptoms, and adherence to cancer treatment, while reducing their unplanned use of healthcare resources. This population-based trial uses a cluster-randomized, stepped wedge design to evaluate the full population of patients managed within Mayo Clinic Midwest medical oncology practices irrespective of cancer type or stage.
Tracking Information
- NCT #
- NCT03892967
- Collaborators
- National Cancer Institute (NCI)
- Investigators
- Principal Investigator: Andrea L Cheville Mayo Clinic
Get Well Soon